People · Operator
Named in public records as an officer, director or promoter · active 2010–2023 · Healthtech, Biotechnology, Energy, Other Health Care, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vertos Medical Inc | — | Healthtech | Series C | $177.3M | $514.0M | 2011 |
| Mevion Medical Systems, Inc. | — | Biotechnology | Series C | $95.3M | $2.4B | 2011 |
| Alucent Biomedical, Inc. | — | Biotechnology | Series B | $46.6M | $134.2M | 2023 |
| Dicom Grid Inc | — | Energy | Series A | $44.5M | $78.2M | 2010 |
| Urgent Care Centers of New England, Inc. | — | Other Health Care | Series A | $32.7M | $186.0M | 2015 |
| Vascular Pathways Inc | — | Other | Series A | $23.6M | $83.7M | 2014 |
Myles Greenberg at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Myles Greenberg on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Daniel Pelak | 2 | 5 |
| James Corbett | 2 | 3 |
| John Ryan | 1 | 17 |
| Stephen Bloch | 1 | 15 |
| Andrew Firlik | 1 | 14 |
| Bruce Feuchter | 1 | 12 |
| Robert Wilson | 1 | 7 |
| Ittai Harel | 1 | 6 |
| Bosun Hau | 1 | 6 |
| Amir Belson | 1 | 6 |
| Mitchell Bloom | 1 | 6 |
| Daniel M. Watkins | 1 | 5 |
| Kenneth Gall | 1 | 5 |
| Anders Hove | 1 | 4 |
| Jay Moorin | 1 | 4 |
| Mary Ann Tocio | 1 | 4 |
| Daniel Watkins | 1 | 4 |
| Nick Pappas | 1 | 4 |
| Michael Elliot | 1 | 4 |
| Richard Kresch | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.